A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery
Condition:   Breast Cancer Interventions:   Drug: ARV-471;   Drug: Anastrozole;   Procedure: Surgical resection of breast tumor Sponsors:   Arvinas Inc.;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2022 Category: Research Source Type: clinical trials